phosphorylethanolamine has been researched along with Depressive Disorder, Major in 3 studies
phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.
Depressive Disorder, Major: Disorder in which five (or more) of the following symptoms have been present during the same 2-week period and represent a change from previous functioning; at least one of the symptoms is either (1) depressed mood or (2) loss of interest or pleasure. Symptoms include: depressed mood most of the day, nearly every daily; markedly diminished interest or pleasure in activities most of the day, nearly every day; significant weight loss when not dieting or weight gain; Insomnia or hypersomnia nearly every day; psychomotor agitation or retardation nearly every day; fatigue or loss of energy nearly every day; feelings of worthlessness or excessive or inappropriate guilt; diminished ability to think or concentrate, or indecisiveness, nearly every day; or recurrent thoughts of death, recurrent suicidal ideation without a specific plan, or a suicide attempt. (DSM-5)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Tomita, R | 1 |
Hayama, T | 1 |
Nishijo, N | 1 |
Sogawa, R | 1 |
Shimanoe, C | 1 |
Fujioka, T | 1 |
Kawamura, N | 1 |
Shinoda, K | 1 |
Sato, H | 1 |
Sasaki, K | 1 |
Suzuki, M | 1 |
Yamaki, K | 1 |
Fujimori, T | 1 |
Yamamoto, H | 1 |
Osei-Hyiaman, D | 1 |
Ohashi, Y | 1 |
Harper, DG | 1 |
Jensen, JE | 1 |
Ravichandran, C | 1 |
Sivrioglu, Y | 1 |
Silveri, M | 1 |
Iosifescu, DV | 1 |
Renshaw, PF | 1 |
Forester, BP | 1 |
3 other studies available for phosphorylethanolamine and Depressive Disorder, Major
Article | Year |
---|---|
Liquid Chromatographic Determination of o-Phosphoethanolamine in Human Plasma Using Fluorescent Derivatization.
Topics: Chromatography, High Pressure Liquid; Depressive Disorder, Major; Ethanolamines; Humans; Indicators | 2023 |
Plasma metabolome analysis of patients with major depressive disorder.
Topics: Adult; Biomarkers; Cohort Studies; Depressive Disorder, Major; Ethanolamines; Female; Humans; Male; | 2018 |
Tissue-specific differences in brain phosphodiesters in late-life major depression.
Topics: Aged; Aged, 80 and over; Aging; Brain; Case-Control Studies; Depressive Disorder, Major; Ethanolamin | 2014 |